ADMA - ADMA Biologics provides Q4 and FY guidance; shares rise
2024-01-08 12:32:21 ET
More on ADMA Biologics
- ADMA Biologics: Achieving Important Inflection Points
- ADMA Biologics Q3 2023 Earnings Call Transcript
- ADMA Biologics refinances its credit facilities with Ares Management
- ADMA Biologics gets label expansion for Bivigam in pediatric setting
- Seeking Alpha’s Quant Rating on ADMA Biologics
For further details see:
ADMA Biologics provides Q4 and FY guidance; shares rise